Eli Lilly said on Sunday its drug Zepbound was superior to Novo Nordisk's Wegovy across five weight-loss targets such as ...

People taking Eli Lilly's obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk's Wegovy in ...

Being overweight or obese is the second biggest cause of cancer in the UK, causing more than one in 20 cancer cases, ...

At 72 weeks, participants using Zepbound saw an average weight-loss reduction of 20.2% versus 13.7% with Novo Nordisk’s own ...

Obesity is linked to 13 different cancers. Scientists have long known that losing weight can slash the risk of cancer, but ...

Restricting the eating window to 8 hours at any time of day for 3 months can result in significant weight loss for at least a ...

A survey shows Gen Z favoring weight loss drugs like Ozempic and Wegovy over exercise and diet for reaching their weight loss ...

In fact, co-lead author, Dr Yael Wolff Sagy from Tel-Aviv, Israel, said researchers found a "direct effect" of GLP-1s beyond ...

Weight-loss injections known as GLP-1 receptor agonists could nearly halve the risk of obesity-related cancers, according to ...

Christopher Schwarzenegger opened up about his dramatic weight loss transformation at the Inaugural Beacher Vitality Happy & ...

WeightWatchers filed for bankruptcy on Tuesday as Americans shunned its offerings in favor of Novo and Lilly drugs and copies ...

Dietitians agree that myths like carbs make you gain weight and you need to track calories and macros can cause more harm ...